A total of 257 untreated patients ( 60-95 years of age ) with new-onset epilepsy underwent objective assessment of executive function ( EpiTrack ) and performed subjective ratings of cognition ( Portland Neurotoxicity Scale ) and quality of life ( QoL ; QOLIE-31 ) .